FDA Inspection 1182334 — Lin, James P MD Inc. D.B.A. Reproductive Fertility Center
The FDA completed an inspection of Lin, James P MD Inc. D.B.A. Reproductive Fertility Center on Oct 19, 2022 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 19, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Irvine, CA (United States)